AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 22 min read$OKLO

DeWitte Jacob sold $3.2M of OKLO

DeWitte Jacob (Co-Founder, CEO) sold 60,000 shares of Oklo Inc. (OKLO) at $52.80 ($3.17M total) on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DeWitte Jacob
Published Jul 2, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:43 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$OKLO
Neutral
medium confidence
Mentioned
$OKLO
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The newest disclosed fact is the CEO/co-founder’s open-market sale of 60,000 shares at $52.80 on July 1 under a 10b5-1 plan, leaving 511,533 shares.

02

Market read

This provides a concrete insider selling datapoint, but it is not a fundamental catalyst given the pre-arranged nature of the trade.

03

What to watch

Traders may over-weight insider sales; without accompanying guidance, financing, or operational updates, the signal is likely weak.

Relevance 5/10Novelty 3/10Timing: filed July 2, covering a July 1 sale

Background

The article is an SEC Form 4 insider transaction report for Oklo Inc., filed July 2, 2026.

Company-level read

Ticker impact

$OKLONeutralMedium confidence
Context

Oklo co-founder and CEO DeWitte Jacob sold 60,000 shares on July 1 at $52.80 via a pre-arranged 10b5-1 plan.

Expected impact

Limited near-term impact; any reaction is likely short-lived unless accompanied by other company-specific news.

Evidence & confidence

Form 4 discloses the sale size and price, but the presence of a pre-arranged 10b5-1 plan reduces the likelihood of it reflecting new negative information.

Market effects

Sector

No direct sector read-through; this is company-specific insider transaction disclosure.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the sale is explicitly under a pre-arranged 10b5-1 plan, the transaction may be mechanically scheduled and not predictive of near-term fundamentals.

Key entities

  • issuer
    Oklo Inc.

    Subject of the Form 4 insider sale disclosure.

  • insider
    DeWitte Jacob

    Co-Founder and CEO, reported the sale under a 10b5-1 plan.

Read at source← All news

Related articles

AUG 9
$OKLOMed

Oklo’s Groves Research Reactor Achieves First Criticality

Oklo (NYSE: OKLO) said its Groves Isotope Test Reactor reached first criticality on private land, supported by DOE Reactor Pilot Program authorization. Los Alamos’ ZiaCore microreactor also achieved zero-power criticality. ARC Clean Technology (ARC) outlined plans for ARC-100 at INL and a term sheet for Turkey. Holtec, Entergy and Hyundai will evaluate SMR-300 projects in Gulf states.

neutronbytes.com6 min
AUG 7
$OKLOMed

Oklo Inc. Q2 2026 Earnings Call Summary

Oklo Inc. reported progress from its Q2 2026 earnings call, including first criticality at the Groves isotope facility and plans for Aurora deployments at INL and an Ohio clean energy campus. The company targeted 2028 commercial startup, expected first isotope revenue in early 2027, and raised 2026 operating cash use guidance to $120M-$150M and PP&E spend to $400M-$500M.

yahoo.com10 min
AUG 7
$OKLOMed

Oklo Stock Attempts a Turnaround, but Technical Barriers Remain as It Releases Q2 2026 Financial Results

Oklo reported Q2 2026 revenue of $1.2 million, above analysts’ ~$83,800 estimate, but posted a $0.28 per-share loss versus a ~$0.16 consensus. Net loss widened to $48.5 million from $24.7 million a year earlier. The company ended the quarter with about $3 billion in cash and marketable securities and said its Groves Isotope Test Reactor achieved first criticality.

fxleaders.com6 min
AUG 7
$OKLOMedAI 8/10

Oklo reports $1.21M Q2 revenue, $1.6B cash as Aurora milestones advance

Oklo Inc. (NYSE: OKLO) reported Q2 2026 revenue of $1.21M versus a $126,250 analyst estimate and an EPS loss of $(0.28) versus an estimated $(0.16). The company said it ended the quarter with $1.6B cash and expects 2026 operating cash flow of $120M to $150M and capex of $400M to $500M. It also advanced Aurora regulatory steps and said its Groves reactor reached first criticality.

scanx.trade7 min